ORIGINAL RESEARCH
Accepted on 14 Oct 2025
Targeting asparagine potentiates anti-PD-L1 immunotherapy in gastric cancer by enhancing CD8⁺ T cell anti-tumor response
doi 10.3389/fimmu.2025.1626581
- 152 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Exploring key pathways in the progression of gastrointestinal diseases based on metabolic reprogramming and developing drugs targeting metabolism
Exploring key pathways in the progression of gastrointestinal diseases based on metabolic reprogramming and developing drugs targeting metabolism
4,011
Total downloads
18k
Total views and downloads
Articles
REVIEW
Published on 14 Oct 2025
Metabolic syndrome in colorectal cancer liver metastasis: metabolic reprogramming and microenvironment crosstalk
doi 10.3389/fimmu.2025.1653442
- 443 views
ORIGINAL RESEARCH
Published on 26 Aug 2025
Decoding the hypoxic tumor microenvironment in colorectal cancer for prognostic modeling and therapeutic target discovery
doi 10.3389/fimmu.2025.1651749
- 1,773 views
REVIEW
Published on 15 Jul 2025
Clinical application prospects of traditional Chinese medicine as adjuvant therapy for metabolic reprogramming in colorectal cancer
doi 10.3389/fimmu.2025.1630279
- 2,011 views
REVIEW
Published on 11 Jul 2025
Lipid metabolic reprogramming in colorectal cancer: mechanisms and therapeutic strategies
doi 10.3389/fimmu.2025.1603032
- 2,854 views
ORIGINAL RESEARCH
Published on 16 Jun 2025
Sphingosine-1-phosphate stimulates colorectal cancer tumor microenvironment angiogenesis and induces macrophage polarization via macrophage migration inhibitory factor
doi 10.3389/fimmu.2025.1564213
- 2,649 views
REVIEW
Published on 12 Jun 2025
Endostatin-based anti-angiogenic therapy and immune modulation: mechanisms and synergistic potential in cancer treatment
doi 10.3389/fimmu.2025.1623859
- 1,889 views
- 4 citations
REVIEW
Published on 06 May 2025
Mechanism of action and therapeutic value of anoctamin-1 in gastrointestinal cancers
doi 10.3389/fimmu.2025.1599100
- 1,575 views
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore